Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02489773 · ClinicalTrials.gov registry record

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

A clinical trial of Diabetes, sponsored by Asahi Kasei Pharma Corporation.

Completed
Registry status
150
Enrollment target
8
Study locations

NCT02489773 is a study of Diabetes that has completed, run by Asahi Kasei Pharma Corporation. The registered enrollment target is 150 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02489773, a study of Diabetes, has completed, sponsored by Asahi Kasei Pharma Corporation.

COMPLETED
Registry status
150 participants
Enrollment target
8
Study locations

Study Summary

To confirm that Lucica ® Glycated Albumin-L is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes.

Conditions Studied

Diabetes

Study Locations (8)

California

  • National Research Institute - Huntington Park - Los Angeles
  • National Research Institute-Westlake - Los Angeles

Texas

  • Texas Diabetes & Endocrinology, P.A. -Austin - Austin
  • Dallas Diabetes and Endocrine Center - Dallas

Kentucky

  • Kentucky Diabetes Endocrinology Center - Lexington

Louisiana

  • Tulane University - New Orleans

Nebraska

  • University of Nebraska Medical Center - Omaha

Washington

  • Capital Clinical Research Center - Olympia

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2015-06
Est. Completion 2016-07

Sponsor

Asahi Kasei Pharma Corporation

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02489773

The ClinicalTrials.gov registry entry for NCT02489773 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Asahi Kasei Pharma Corporation, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT02489773 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Texas, Kentucky.

Frequently Asked Questions

What is clinical trial NCT02489773 about?

NCT02489773 is a clinical study titled "Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study". To confirm that Lucica ® Glycated Albumin-L is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes.

What is the current status of trial NCT02489773?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2015-06. Estimated completion is 2016-07.

What conditions does trial NCT02489773 study?

This clinical trial studies the following conditions: Diabetes.

Who is sponsoring clinical trial NCT02489773?

This trial is sponsored by Asahi Kasei Pharma Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02489773 being conducted?

This trial has 8 study locations across California, Kentucky, Louisiana, Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.